Latest / Community Health Media
Dr. VK Gadi & Dr. Jason Mouabbi - HER2 Positive & HER2 Low Updates and Therapies
Join Dr. VK Gadi and Dr. Jason Mouabbi at a recent conference for their discussion around the changing function of antibody-drug conjugates (ADCs) such as T-DXd (trastuzumab deruxtecan) in treating HER2-positive breast cancer, especially in patients with central nervous system (CNS) metastases. The talk hinges on the historical use of tiny compounds like tucatinib to ensure they’re able to pass the blood-brain barrier. New research, however, challenges the conventional wisdom on treatment restrictions by showing that ADCs might also be useful in this environment.
Dr. Mouabbi offered a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.